APA (7th ed.) Citation

Úlehlová, J., Piskláková, B., Ivanovová, E., Procházková, J., Bradáčová, P., Kvasnička, A., . . . Slavík, L. (2021). Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients. MDPI AG.

Chicago Style (17th ed.) Citation

Úlehlová, Jana, Barbora Piskláková, Eliška Ivanovová, Jana Procházková, Pavla Bradáčová, Aleš Kvasnička, David Friedecký, and Luděk Slavík. Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients. MDPI AG, 2021.

MLA (9th ed.) Citation

Úlehlová, Jana, et al. Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients. MDPI AG, 2021.